Bioequivalence and Bioavailability Forum 11:39 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Not using Bio­strength for BE [Regulatives / Guidelines]

posted by zheng791 - US, 2018-07-13 21:31  - Posting: # 19052
Views: 1,031

Hi,
Our firm is developing a multi-strength product which is a high potency, NTI oral dosage. The highest strength is 0.3 mg. The product guidance requests to use 0.3 mg x2 tablets for dosing and biowaive the lower strengths. However, our firm does not want to develop 0.3 mg. They have 0.15 mg as highest strength. Can I use 0.15 mg x4 for dosing and biowaive lower strengths? These strengths are similarly proportional, that is have the same tablet weight, the filler weight changes to compensate the API change.

Thank you

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,190 posts in 4,085 threads, 1,308 registered users;
online 30 (0 registered, 30 guests [including 14 identified bots]).

The aim of science is not to open the door to infinite wisdom,
but to set a limit to infinite error.    Bertolt Brecht

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed